Technical Analysis for GDR - Genedrive Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | -4.26% | |
| NR7 | Range Contraction | -4.26% | |
| NR7-2 | Range Contraction | -4.26% | |
| Narrow Range Bar | Range Contraction | -4.26% | |
| Wide Bands | Range Expansion | -4.26% | |
| NR7 | Range Contraction | -4.26% | |
| NR7-2 | Range Contraction | -4.26% | |
| Narrow Range Bar | Range Contraction | -4.26% |
| Alert | Time |
|---|---|
| Down 10% | about 8 hours ago |
| Down 5% | about 8 hours ago |
| Down 3% | about 8 hours ago |
| 20 DMA Support | about 8 hours ago |
| Fell Below Previous Day's Low | about 11 hours ago |
Get a Trading Assistant
Genedrive Plc Description
Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Gas Biotechnology Life Sciences Disease Clinic Drugs Laser Oncology Testing Skin Drug Development Skin Care E Testing Health Sciences Molecular Omics Clinical Research Genomics Microscopy Molecular Diagnostics Pharmacology Medical Genetics Profiling Pharmacogenomics Pre Clinical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.9 |
| 52 Week Low | 2.555 |
| Average Volume | 3,211,462 |
| 200-Day Moving Average | 8.50 |
| 50-Day Moving Average | 4.83 |
| 20-Day Moving Average | 5.33 |
| 10-Day Moving Average | 5.89 |
| Average True Range | 0.86 |
| RSI (14) | 53.27 |
| ADX | 37.54 |
| +DI | 27.17 |
| -DI | 11.65 |
| Chandelier Exit (Long, 3 ATRs) | 7.31 |
| Chandelier Exit (Short, 3 ATRs) | 5.14 |
| Upper Bollinger Bands | 7.77 |
| Lower Bollinger Band | 2.90 |
| Percent B (%b) | 0.56 |
| BandWidth | 91.36 |
| MACD Line | 0.33 |
| MACD Signal Line | 0.33 |
| MACD Histogram | 0.0054 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.19 | ||||
| Resistance 3 (R3) | 6.25 | 6.13 | 6.09 | ||
| Resistance 2 (R2) | 6.13 | 5.98 | 6.09 | 6.06 | |
| Resistance 1 (R1) | 5.88 | 5.89 | 5.81 | 5.81 | 6.03 |
| Pivot Point | 5.75 | 5.75 | 5.72 | 5.72 | 5.75 |
| Support 1 (S1) | 5.50 | 5.61 | 5.44 | 5.44 | 5.22 |
| Support 2 (S2) | 5.38 | 5.52 | 5.34 | 5.19 | |
| Support 3 (S3) | 5.13 | 5.38 | 5.16 | ||
| Support 4 (S4) | 5.06 |
